• About
  • Board
  • News
  • Sign Up
  • Contact

Visit

VJHemOnc
Logo
  • Home (current)
  • Diseases
    ALL
    AML
    CLL
    Lymphoma
    Multiple Myeloma
    Myeloproliferative Neoplasms
    View all Diseases
  • Topics
    Measurable Residual Disease
    CAR-T & Cellular Therapy
    Pharmacy
    Nursing
    Supportive Care
    Transplantation
    View all Topics
  • Conferences
    ASH
    2018
    UKONS
    2018
    ERIC
    2018
    BOPA
    2018
    ESH MM
    2018
    EORTC CLTF
    2018
    View all Conferences
  • Features
  • Podcasts
    • About
    • Board
    • News
    • Sign Up
    • Contact

immunotherapy

1:59
Multiple myeloma musings: highlights from 2018 data
Joshua Richter
04:11
An exciting era for CAR T-cell therapy
Mohamad Mohty
03:22
JCAR017 for relapsed/refractory CLL
Tanya Siddiqi
2:42
Tislelizumab for R/R classical Hodgkin lymphoma
Yuqin Song
2:49
The CAR-T tsunami: an overview & brief history
Michel Sadelain
4:17
Intestinal microbiota may unlock the true potential of HCT
Jonathan Peled
1:14
Off-the-shelf CAR T-cell therapy
Dietmar Berger
2:20
Telomere length can predict the outcome of FCR chemoimmunotherapy in CLL
Christopher Fegan
2:19
AMG 420 BiTE for R/R multiple myeloma
Thierry Facon
2:23
The MAIA study and other myeloma highlights from ASH 2018
Gareth Morgan
0:55
CAR-T and ibrutinib in combination: a promising treatment for CLL
Lydia Scarfò
4:04
bb21217 results: a next-generation anti-BCMA CAR-T for R/R MM
Nina Shah
2:53
Early look at data for CAR-T bb21217 in R/R MM
Noopur Raje
1:29
CAR T-cell updates in CLL
William Wierda
2:28
Predictors of expansion/response to anti-BCMA CAR T-cells in R/R multiple myeloma
Adam Cohen
2:25
PD-1 blockade as salvage following anti-BCMA CAR-T in R/R myeloma
Adam Cohen
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 23
  • Next
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

Please enter your details if you would like to receive the latest Hemonc news and updates

Continue
Video channels
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Acute Promyelocytic Leukemia
  • Amyloidosis
  • Anemia
  • Aplastic Anemia
  • B-Cell Lymphoma
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
  • CNS Lymphoma
Join our community

Keep up-to-date via social media

Sign up for email updates

Get great new content delivered to your inbox

Sign up

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

The content of VJHemOnc is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use